Ortho Clinical Diagnostics and EKF Diagnostics have entered an agreement to make EKF’s Beta-Hydroxybutyrate (BHB) LiquiColor assay available on Ortho’s Vitros 4600 chemistry system and Vitros 5600 integrated system. This assay determines the presence and degree of ketosis in suspected diabetic ketoacidosis cases, and works by producing a quantitative value that is specific to the BHB ketone body. The Food and Drug Administration has classified the assay as moderate complexity under CLIA. Under the terms of this collaboration, Ortho and EKF will provide the BHB assay as a validated MicroTip partnership assay (MPA) application in the U.S. and Canada. As an MPA assay, the test will include a user-defined assay feature that enables users to program assay parameters as defined in the EKF-Stanbio assay application sheet.